VISSIT Intracranial Stent Study for Ischemic Therapy "VISSIT"


Phase 2/3 Results

Summary of Purpose

The main objective of this study is to prospectively evaluate the safety, probable benefit, and effectiveness of the PHAROS Vitesse Neurovascular Stent System in a multicenter, randomized clinical trial. A secondary objective of this study is to evaluate the impact of stenting in the neurovasculature to treat cerebral ischemia on other outcomes such as hospital length of stay, charges, and costs.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 February 2015.

1 Oct 2008 29 Dec 2008 1 Apr 2013 1 Jun 2014 1 Feb 2015 18 Apr 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment